Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine Versus Placebo as Adjuvant Treatment for Major Depressive Disorder and Wish to Hasten Death in Advanced Cancer Patients Undergoing Palliative Care


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04471818

Organisation Name: Instituto Nacional de Cancerologia de Mexico

Overal Status: Recruiting

Start Date: November 19, 2019

Last Update: July 15, 2020

Lead Sponsor: Instituto Nacional de Cancerologia de Mexico

Brief Summary: Major depression (MD) is a psychiatric disorder characterized by a persistent feeling of sadness, anhedonia or a decreased perception of pleasurable experiences, as well as appetite alterations and weight variations, sleep disorders, altered psychomotor skills, fatigue, guilt, decreased self-worth, suicidal thoughts and difficulty concentrating in a task (1).

MD is a frequent complication in patients who are diagnosed with advanced cancer.

Conditions:
  • Major Depressive Disorder
  • Advanced Cancer


Total execution time in seconds: 0.1843249797821